Author: Carly Behm

Robert Watkins IV, MD, operated on Las Vegas Golden Knights captain Mark Stone, the team said May 19.

Two surgeons are asking a judge to reverse the dismissal of a False Claims Act case against Johnson & Johnson related to hip replacement devices.

Accelus' Toro-L interbody fusion system was cleared by the FDA.

Bonesupport's Cerament G, an injectable combination antibiotic bone graft substitute, earned FDA market authorization.

Keith Meister, MD, operated on Minnesota Twins pitcher Chris Paddack, the team said May 18.

Two professional athletes decided to forgo surgery in favor of stem cell and platelet-rich-plasma injections in the last week.

Regenerative medicine in spine and orthopedics is gaining momentum, and many surgeons expect further development and research for the field in the near future.

Castle Connolly's "2022 Rising Stars" list recognizes early-career physicians across several specialities for their accomplishments.

Medtronic finalizes a $1.1 billion acquisition and five more updates from spine and orthopedic device companies in the last week:

Grant Zarzour, MD, is observing private equity, management service organizations and other forms of partnerships in orthopedics closely.